G-1 exposure and/or GPER signaling impacted the progression of various hormone-responsive tumors such as ovarian [41,42,43], endometrial [44,45], breast [46] and testicular germ cell tumors. This evidence concerns the gene GPER1 and testicular germ cell tumor.